Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Kineta Inc (KA)

Kineta Inc (KA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.5746 -0.2544 (-30.69%) 09/18/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.5746 unch (unch) -
Quote Overview for Wed, Sep 18th, 2024
Day Low
0.5599
Day High
0.8250
Open 0.7801
Previous Close 0.8290 0.8290
Volume 530,700 530,700
Avg Vol 92,860 92,860
Stochastic %K 53.49% 53.49%
Weighted Alpha -53.75 -53.75
5-Day Change -0.1978 (-25.61%) -0.1978 (-25.61%)
52-Week Range 0.3339 - 5.3900 0.3339 - 5.3900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,041
  • Shares Outstanding, K 12,254
  • Annual Sales, $ 5,440 K
  • Annual Income, $ -14,100 K
  • EBIT $ -17 M
  • EBITDA $ -17 M
  • 60-Month Beta 0.46
  • Price/Sales 1.87
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.74
  • Most Recent Earnings $-0.20 on 08/08/24
  • Next Earnings Date 11/01/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5599 +2.63%
on 09/18/24
Period Open: 0.5640
0.8890 -35.37%
on 09/16/24
+0.0106 (+1.88%)
since 08/16/24
3-Month
0.4700 +22.26%
on 06/20/24
Period Open: 0.4995
0.8890 -35.37%
on 09/16/24
+0.0751 (+15.04%)
since 06/18/24
52-Week
0.3339 +72.09%
on 04/16/24
Period Open: 2.2100
5.3900 -89.34%
on 10/03/23
-1.6354 (-74.00%)
since 09/18/23

Most Recent Stories

More News
Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors

KA : 0.5746 (-30.69%)
KANT : 0.3091 (-20.74%)
Kineta Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024

KA : 0.5746 (-30.69%)
KANT : 0.3091 (-20.74%)
Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board

/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Board of Directors has...

PHAR : 8.78 (+0.63%)
KA : 0.5746 (-30.69%)
APRE : 2.24 (+2.28%)
XFOR : 0.2694 (+3.86%)

Business Summary

Kineta, Inc. is a clinical-stage biotechnology company. It develops next-generation immunotherapies that address the major challenges with current cancer therapy. The company's lead asset is KVA12123, a novel VISTA blocking immunotherapy. Kineta merged with Yumanity Therapeutics, Inc., and is based...

See More

Key Turning Points

3rd Resistance Point 1.0115
2nd Resistance Point 0.9183
1st Resistance Point 0.7464
Last Price 0.5746
1st Support Level 0.4813
2nd Support Level 0.3881
3rd Support Level 0.2162

See More

52-Week High 5.3900
Fibonacci 61.8% 3.4586
Fibonacci 50% 2.8619
Fibonacci 38.2% 2.2653
Last Price 0.5746
52-Week Low 0.3339

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies